Indopedia All Things Marijuana
Photo via Bim
The medical cannabis industry is one of the fastest-growing markets in the world today, and many entrepreneurs have been willing to risk bending the law to provide medicine to an increasing number of users. Swiss canna-business CBD420 is one such company which relies on legal loopholes to sell their low-THC CBD products in several European nations, reports The Guardian. The company’s BlueDream strain is for sale in 1,000 Swiss tobacco shops as well as a small handful of French shops, and has a low-enough THC content to escape the notice of most regulators—so far.
Almost every European country still has laws prohibiting cannabis on the books, but CBD420 founder Jonas Duclos told The Guardian that “there is a loophole that lets us bring it on the market.” By strictly limiting the quantity of THC in its products and not marketing CBD as a medicine, the company is able to get around laws prohibiting the sale of the product within the E.U. CBD420 is also testing the waters in France, sending small orders of 100 jars at a time to prevent a crackdown from French authorities.
“If the French government goes against [allowing CBD to be imported] then that…
